- Filed
- Apr 30, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 55.68M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $0 |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $522K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $85.28M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $89.37M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $110.29M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $112.62M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $350.24M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $351.83M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $489.64M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $491.05M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $114.69M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $93.3M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 51.69M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$15.31M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $256.23M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $261.33M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.38 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.38 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $30.14M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $18.71M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$19.89M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$22.57M |
| Revenue | Q1 2025 · Mar 31, 2024 | $72.05M |